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Bordetella pertussis, B. bronchiseptica, B. parapertussishu, and B. parapertussisov are closely related respiratory
pathogens that infect mammalian species. B. pertussis and B. parapertussishu are exclusively human pathogens and
cause whooping cough, or pertussis, a disease that has resurged despite vaccination. Although it most often infects
animals, infrequently B. bronchiseptica is isolated from humans, and these infections are thought to be zoonotic. B.
pertussis and B. parapertussishu are assumed to have evolved from a B. bronchiseptica–like ancestor independently. To
determine the phylogenetic relationships among these species, housekeeping and virulence genes were sequenced,
comparative genomic hybridizations were performed using DNA microarrays, and the distribution of insertion
sequence elements was determined, using a collection of 132 strains. This multifaceted approach distinguished four
complexes, representing B. pertussis, B. parapertussishu, and two distinct B. bronchiseptica subpopulations, designated
complexes I and IV. Of the two B. bronchiseptica complexes, complex IV was more closely related to B. pertussis.O f
interest, while only 32% of the complex I strains were isolated from humans, 80% of the complex IV strains were
human isolates. Comparative genomic hybridization analysis identified the absence of the pertussis toxin locus and
dermonecrotic toxin gene, as well as a polymorphic lipopolysaccharide biosynthesis locus, as associated with
adaptation of complex IV strains to the human host. Lipopolysaccharide structural diversity among these strains was
confirmed by gel electrophoresis. Thus, complex IV strains may comprise a human-associated lineage of B.
bronchiseptica from which B. pertussis evolved. These findings will facilitate the study of pathogen host-adaptation.
Our results shed light on the origins of the disease pertussis and suggest that the association of B. pertussis with
humans may be more ancient than previously assumed.
Citation: Diavatopoulos DA, Cummings CA, Schouls LM, Brinig MM, Relman DA, et al. (2005) Bordetella pertussis, the causative agent of whooping cough, evolved from a
distinct, human-associated lineage of B. bronchiseptica. PLoS Pathog 1(4): e45.
Introduction
The genus Bordetella is composed of several species, of
which three are exclusively respiratory pathogens of mam-
malian hosts: B. bronchiseptica, B. pertussis, and B. parapertussis
(henceforth referred to as the mammalian bordetellae). B.
bronchiseptica causes chronic and often asymptomatic respira-
tory tract infections in a wide variety of mammals. It is only
sporadically isolated from humans [1,2], particularly from
immunocompromised individuals, and human infections
have been considered to be zoonotic [3]. B. parapertussis
consists of two distinct lineages: one found in humans and the
other found in sheep (B. parapertussishu and B. parapertussisov,
respectively) [4]. B. pertussis and B. parapertussishu have been
isolated only from humans and cause acute, transient
infections and disease, designated whooping cough or
pertussis. Pertussis is especially severe in young, unvaccinated
children and has reemerged in recent years in vaccinated
populations [5–7]. Previous research indicated that B. pertussis
and B. parapertussishu independently evolved from a B.
bronchiseptica–like ancestor [8.9], and comparison of the
g e n o m e so ft h et h r e ei s o l a t e sc h o s e nf o rs e q u e n c i n g
suggested that the time to the last common ancestor (LCA)
for B. pertussis and B. parapertussishu and for B. bronchiseptica was
0.7 to 3.5 and 0.27 to 1.4 million years, respectively [10].
Despite their different host tropisms, the mammalian
bordetellae are very closely related [8,9]. Analysis of their
genome sequences revealed that the adaptation of B. pertussis
and B. parapertussishu to the human host was accompanied by
extensive genome decay [10].
Their differences in host tropism in contrast to their close
genetic relationships make the mammalian bordetellae
attractive candidates for the study of host-adaptation. Such
studies are facilitated by the availability of genome sequences
of B. bronchiseptica, B. pertussis, and B. parapertussishu [10]. So far,
only a single representative of each species has been
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ships to the Bordetella population as a whole. To that end and
to identify genetic events that may be associated with host
adaptation, we used a combination of multilocus sequence
typing (MLST) [11], comparative genomic hybridization
(CGH) with whole-genome microarrays [12], and the distri-
bution of several insertion sequence elements (ISEs) to
characterize 132 mammalian Bordetella strains with diverse
host associations. This work identiﬁed two B. bronchiseptica
lineages, the ﬁrst of which is composed of mainly strains of
animal origin and includes the B. bronchiseptica strain from
which the genome sequence has been determined. The
second lineage, comprising strains mainly of human origin,
is more closely related to B. pertussis than the ﬁrst lineage.
Comparison of the two B. bronchiseptica lineages to B. pertussis
revealed genetic differences that may be associated with
adaptation to the human host.
Results
Population Structure of the Mammalian Bordetellae,
Based on Multilocus Sequence Typing
To determine the relationships between the mammalian
bordetellae, we determined the partial sequences of seven
housekeeping genes from 132 strains (Table S1 and http://
pubmlst.org/bordetella). We observed 32 sequence types (STs)
among the 132 Bordetella isolates. Allele segments were divided
into ﬁve equally sized subloci, and a minimum spanning tree
(MST) algorithm was used to cluster the subloci [13].
Complexes were deﬁned as groups of strains differing at fewer
thanﬁveof35sublociwithaminimumoftwoSTspercomplex.
Using this criterion, strains could be assigned to one of four
complexes, designated complexes I through IV (Figure 1).
Complexes II and III contained the B. pertussis and B.
parapertussishu isolates, respectively. Both of these complexes
showed very limited genetic diversity (H ¼ 0.65 and 0.35,
respectively), as described previously [8,9]. B. bronchiseptica was
divided into two distinct populations, designated complexes I
and IV, respectively. The genetic diversity of these two
complexes (H ¼ 2.16 and 2.45, respectively) was much higher
than that of complexes II and III. Complex I contained the
majority of the B. bronchiseptica strains (76 of 91 strains),
including the sequenced RB50 strain. In addition, it contained
the B. parapertussisov isolates in the study population (ST16). B.
bronchisepticacomplex IV was more closelyrelated to B.pertussis
than was B. bronchiseptica complex I. Furthermore, the host
species associations of the two complexes were quite distinct.
Of the B. bronchiseptica complex IV isolates, 80% were isolated
from humans, while this was the case for only 32% of the
complex I isolates. It should be noted that human B.
bronchiseptica isolates were overrepresented in our strain
collection, in comparison with their occurrence in natural
populations. However, the human complex IV isolates origi-
nated from different continents, comprising North America,
South America, and Europe. Previously, phylogenetic analysis
based on CGH suggested the existence of a distinct B.
bronchiseptica lineage that was closely related to B. pertussis [12].
The relationships among the mammalian bordetellae
inferred from housekeeping gene sequences were conﬁrmed
by an analysis based on the pertactin gene (prn), which codes
for a surface-associated virulence factor involved in adher-
ence [14,15]. A UPGMA tree was constructed from the aligned
prn sequence data, and the topology of this tree was very
similar to the MLST tree (Figure 2). B. bronchiseptica strains are
grouped into two lineages, corresponding to complex I and
IV in the MLST tree. Also, B. bronchiseptica complex IV and B.
pertussis strains clustered together in one branch, which was
supported by bootstrapping. B. parapertussishu comprised a
separate branch within a larger cluster that also contained
the B. bronchiseptica complex I strains. The B. parapertussisov
strains were indistinguishable from B. bronchiseptica complex I
strains, as was observed in the MLST tree.
Distribution of Insertion Sequence Elements
The distribution of ISEs has been used to reveal evolu-
tionary relationships among the Bordetella population [9].
Toward this end, we screened our strain collection for the
presence of IS481,I S 1001,I S 1002, and IS1663 using PCR
(Table S1). The distribution of the ISEs was mapped onto the
MST (see Figure 1). IS481 was detected in all B. pertussis strains
but not in any other species, with the exception of two B.
bronchiseptica isolates, both from a horse (B1975, B0230, ST6),
consistent with previous observations [9,16]. IS1001 was
detected in all B. parapertussishu and B. parapertussisov strains.
Additionally, IS1001 was detected in most (21 of 25) B.
bronchiseptica strains belonging to ST7 in complex I, but not in
other STs, including STs in complex II and IV. IS1002 was
detected only in B. pertussis and in B. parapertussishu strains,
conﬁrming previous observations [4,9]. IS1663 [10] was
detected in all B. pertussis isolates but also in ten of 13 B.
bronchiseptica complex IV strains. The three complex IV strains
in which IS1663 was not detected belonged to STs 18 and 21.
Divergence Times of Complexes
Under the assumption that the mutation rate in prokar-
yotes is relatively constant, the time since descent from the
LCA can be estimated using pairwise mean allele distances
(KS) [17,18]. The clock rates described by Whittam [19] and by
Guttman and Dykhuizen [20] were used to estimate a range of
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Synopsis
Bordetella pertussis causes whooping cough, which kills 300,000
persons annually, and is reemerging despite vaccination. This
human-restricted species is closely related to the respiratory
pathogens B. parapertussishu, which is also human restricted, and
B. bronchiseptica, which infects a broad range of mammals. Based on
its limited genetic diversity and lack of historical descriptions, it has
been suggested that the association between B. pertussis and
humans is recent. In this study, the authors examined the genetic
diversity and evolutionary relationships of these three Bordetella
species. Their results suggest that B. parapertussis evolved from an
animal-associated lineage of B. bronchiseptica, while B. pertussis
evolved from a distinct B. bronchiseptica lineage that may already
have had a preference for hominids up to 2.5 million years ago.
Extant members of this newly identified B. bronchiseptica lineage
were found to circulate in human populations. Comparisons of gene
content revealed genomic features that are shared by and specific
to B. pertussis and the B. bronchiseptica human-associated lineage
and that may be important for association with the human host.
These two lineages also have differences in key virulence genes that
may reflect immune competition in the human host. By elucidating
the evolutionary origins of human-adapted Bordetella, this study
sets the stage for identification of key molecular events in host
adaptation.divergence times between complexes. Calculations indicated
that B. pertussis and B. bronchiseptica complex IV separated
approximately 0.3 to 2.5 million years ago (Mya), which
suggests a more recent divergence time than B. pertussis and B.
bronchiseptica complex I, estimated at 1.1 to 5.6 Mya. B.
parapertussishu and B. bronchiseptica complex I diverged between
0.7 and 3.5 Mya according to our calculations. The divergence
times of combinations of complexes is shown in Figure 1.
Gene Content of Strains from B. bronchiseptica Complexes
I and IV
The high percentage of complex IV strains of human origin
compared to the percentage of those in complex I suggested a
preference for the human host in complex IV strains. To
identify genetic events that may have played a role in host
adaptation or host restriction, we used CGH with Bordetella
DNA microarrays [17,18].
Genomic DNA from 26 B. bronchiseptica complex I and 13
complex IV strains was hybridized to microarrays (CGH data
ﬁles have been deposited in ArrayExpress, accession E-
TABM-32). Signiﬁcance Analysis of Microarrays (SAM) was
used to identify probes with statistically signiﬁcant log
intensity ratio differences between the two complexes (Table
S2). This approach detected sequences that have been deleted
more often in one of the two complexes, as well as DNA
sequences diverging from the reference sequences in one of
the two complexes.
Thirty-one probes, representing 29 genes and an ISE,
hybridized more strongly or more frequently to the genomes
of complex IV strains than to those of complex I. Two of these
probes represented the B. pertussis homologs of the virulence
genes prn and tcfA, encoding pertactin and tracheal colo-
nization factor, respectively [15,21] (Figure 3). Sequence
analysis conﬁrmed that the B. bronchiseptica complex IV prn
sequences were more similar to those of B. pertussis than to
those of the B. bronchiseptica complex I (see Figure 2).
Sixteen of these 31 probes had been identiﬁed previously as
B. pertussis–speciﬁc [12]. In most cases, these probes hybri-
dized to nine or more complex IV strains but not to any
complex I or III strain. The genes represented by these probes
encode diverse functions involved in metabolism, transport,
regulation, and transposition (Table S2). With the possible
exception of BP0703, which encodes a TonB-dependent iron
receptor, no obvious virulence genes were observed among
them. Most of the 16 genes were located in small clusters
along the B. pertussis Tohama chromosome. The presence of
these genes in B. bronchiseptica complex IV and B. pertussis but
not in B. bronchiseptica complex I or B. parapertussishu suggests
that they were acquired by the common ancestor of B.
pertussis and B. bronchiseptica complex IV.
We also identiﬁed 248 probes, representing 237 genes, that
exhibited signiﬁcantly stronger hybridization to complex I
genomes than to complex IV genomes (Table S2). Sixty-eight
(27%) corresponded to genes associated with mobile elements
such as prophages, while many of the other probes repre-
sented genes involved in metabolic, transport, and regulatory
functions. Surprisingly, several virulence-associated genes
were found to be missing or divergent in the complex IV
strains, as compared to complex I strains. These included the
B. bronchiseptica homologs of tcfA and prn, Bvg-regulated
intermediate phase gene A (bipA), the alcaligin biosynthesis
locus (alcA/E), the pertussis toxin synthesis and transport locus
Figure 1. Minimum Spanning Tree of B. bronchiseptica, B. pertussis, and B. parapertussis
The tree was based on the sequence of seven housekeeping genes. Individual genes were split into five subloci, and a categorical clustering was
performed. In the minimum spanning tree, sequence types sharing the highest number of single locus variants were connected first. Each circle
represents a sequence type (ST) the size of which is related to the number of isolates within that particular ST. Colors within circles indicate host
distribution. The numbers between connected STs represent the number of different subloci between those STs. The clonal complexes (I, II, III, and IV)
are indicated by colored strips between connected STs. ST16 (B. bronchiseptica complex I) harbors the B. parapertussisov strains. STs containing strains of
which the genome has been sequenced (B. pertussis Tohama, B. parapertussis 12822 or B. bronchiseptica RB50) are indicated by a thickset, dashed line.
The distribution of the insertion sequence elements IS481,I S 1001,I S 1002, and IS1663 is shown in boxes (see also Table S1); numbers between
parentheses indicate the percentage of strains that contained the ISE as determined by PCR amplification. The divergence times between B.
bronchiseptica complexes I and IV and B. pertussis complex II are shown.
DOI: 10.1371/journal.ppat.0010045.g001
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Evolution of Human-Associated Bordetella Species(ptx/ptl), the dermonecrotic toxin gene (dnt), and the lip-
opolysaccharide (LPS) biosynthetic locus (Figures 3 and 4).
Interestingly, ten of 13 complex IV strains harbored
deletions in the ptx and ptl loci, which encode pertussis toxin
(Ptx) and its secretion machinery, respectively (Figure 3)
[22,23]. While conditions under which Ptx is expressed by
either B. parapertussis or B. bronchiseptica have not been found,
the structural genes are generally conserved among these
species [24], suggesting selective pressure to retain the ability
to produce functional Ptx under certain circumstances. The
complex IV strains in which ptx/ptl was still present (ST3/17/29)
were tested for expression of Ptx by immunoblotting, and
these strains were found not to express Ptx under the growth
conditions used (unpublished data). Another distinguishing
characteristic of the complex IV strains was the deletion of the
dermonecrotic toxin gene (dnt) in 8 of 13 strains. In contrast,
this gene was detected in all B. pertussis, B. parapertussishu,B .
parapertussisov, and B. bronchiseptica complex I strains.
LPS Genetic and Structural Diversity in B. bronchiseptica
The genetic structure of the LPS biosynthesis locus differed
between complex I and IV strains. The LPS molecules of
Gram-negative bacteria usually consist of three, covalently
linked, major domains: the lipid A, the branched chain
oligosaccharide core, and the hydrophilic O-antigen. A
number of genetic loci have been implicated in the synthesis
of these domains in Bordetella, such as the lpx locus (lipid A),
the waa locus (inner core), the wlb locus (outer core), and the
wbm locus (O-antigen) [25–29].
B. pertussis LPS usually consists of lipid A and an inner core,
to which the outer core (a trisaccharide) is attached; this is
also referred to as band A. Certain B. pertussis strains produce
only band B, which is identical to band A except that it lacks
the trisaccharide [30]. The O-antigen, which is added to the
trisaccharide, is found only in B. bronchiseptica and B.
parapertussis. This structure is missing in B. pertussis due to
the deletion of the genes wbmA-U [26]. In Figure 4, the gene
content of the LPS locus is shown for 13 complex I and 13
complex IV strains and for B. pertussis Tohama and B.
bronchiseptica RB50. Four LPS gene content proﬁles, desig-
nated LPS 1–4, could be distinguished among the B.
bronchiseptica strains. Strains with the LPS 1 proﬁle had an
LPS gene composition similar to RB50, characterized by the
absence of wbmPQRSTU. The LPS 2 proﬁle was characterized
by the absence of the genes wbmORS and BB0124–BB0127 and
the presence of an alternative O-antigen locus, comprising
wbmPQRSTU, orthologous to the B. parapertussis 12822 genes
[10]. Both of these genotypes appear competent for the
production of a full length LPS. Strains with the LPS 3 proﬁle
lacked wbmD-U and BB0124-BB0127, suggesting that they may
not produce O-antigen. The LPS 4 proﬁle was similar to the
LPS 3 proﬁle but additionally lacked wbmABC and wlbD-L,
suggesting that strains of this genotype may be deﬁcient for
the production of trisaccharide as well as O-antigen. The
deletion in the O-antigen genes of LPS 4 strains was similar to
that observed in the O-antigen genes of B. pertussis Tohama.
All complex I strains displayed either an LPS 1 or an LPS 2
proﬁle. Nine of 13 complex IV strains had either an LPS 1 or
an LPS 2 proﬁle, while four complex IV strains showed more
extensive deletions, resulting in LPS 3 and LPS 4 proﬁles.
To study the effect of these deletions on LPS production,
proteinase K–treated cell lysates were analyzed by Tricine-
SDS-PAGE, followed by silver staining or immunoblotting
with monoclonal antibodies (mAbs) directed against either
band A or band B (mAbs 36G3 and BL-8, respectively [31,32])
(Figure 4). Silver-staining showed that all complex I strains
produced band A, except for B1985, which produced band B,
and B2112, which produced a band migrating at a position
between bands A and B. These strains showed no obvious
deletions at their wlb or wbm loci, and the fact that they did
not produce band A and O-antigen may be attributed to
point mutations, e.g., in their wlb locus, or to regulatory
effects. These results were conﬁrmed by immunoblotting with
mAb 36G3. The epitope in the trisaccharide that is
recognized by this mAb was also present in the O-antigenic
repeats, as was described previously [33]. In general, most
strains that produced band A also produced an additional
band just above band A. This extra band was also recognized
by 36G3 and therefore is likely derived from band A.
The nine complex IV strains with LPS 1 or 2 proﬁles all
produced band A. The two strains with the LPS 4 proﬁle,
B2490 and B2506, produced a band smaller than band A,
which failed to be recognized by mAb 36G3. Of the two
strains with an LPS 3 proﬁle, one strain (B0243) produced
only band B and no O-antigen. Unexpectedly, the other
strain, B2494, produced band A and O-antigen as detected by
immunoblotting, indicating that this strain contains as yet
uncharacterized O-antigen biosynthesis genes. Silver staining
Figure 2. UPGMA Tree Based on the Analysis of the Pertactin Gene of
Bordetella Isolates Used in the MLST Analysis
The DNA segment coding for the extracellular domain of pertactin (P.69)
was used for analysis, with the exclusion of the repeat regions 1 and 2.
Bootstrap values are shown for the nodes separating the complexes and
are based on 500 bootstrap replicates. The scale indicates the genetic
distance along the branches. Colors of the branches indicate the four
complexes defined by MLST. The number of strains of each branch is
shown in boxes, as well as the host distribution.
DOI: 10.1371/journal.ppat.0010045.g002
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although the O-antigen failed to be recognized by mAb 36G3.
Discussion
Although it has long been speculated that B. pertussis evolved
from a B. bronchiseptica strain [8,9], a speciﬁc lineage has not
been identiﬁed. Here we identify and characterize such a B.
bronchiseptica lineage. Analysis of MLST data from the mamma-
lian bordetellae identiﬁed four distinct complexes. Complex I
and IV comprised B. bronchiseptica strains, while complex II and
III comprised the human pathogens B. pertussis and B.
parapertussishu, respectively. Our results suggest that B. pertussis
and B. parapertussishu evolved from complexes I and IV,
respectively, indicating that adaptation to humans occurred
astwoindependentevents,consistentwithpreviousdata[9,10].
The population structure of the mammalian bordetellae
inferred from MLST data largely corresponded with a
maximum parsimony phylogeny derived from a previous
CGH study [12], with the exception of the relationship of B.
parapertussisov and B. parapertussishu. In the current study, B.
parapertussishu and B. parapertussisov are clearly derived from
different STs in complex I. Further, in contrast to B.
parapertussishu, B. parapertussisov is actually part of B. bronchi-
septica complex I. The closer relationship between the sheep-
and human-derived B. parapertussis lineages that was inferred
from CGH data may be an artifact of long-branch attraction
in the maximum parsimony tree [34].
Consistent with previous studies [8,9,35], B. pertussis and B.
parapertussishu showed a relatively low degree of genetic
diversity, suggesting that they evolved recently or encoun-
tered a recent evolutionary bottleneck. Of the three B.
pertussis STs observed, two were found exclusively before
1960, whereas all modern strains belong to ST2. The temporal
shift in B. pertussis STs is consistent with our previous studies
on antigenic shifts that show major changes in the B. pertussis
population after the introduction of mass vaccination against
pertussis in the 1950s and 1960s [35,36].
Most human disease is by far caused by B. pertussis, and we
therefore focused on the relationship of B. bronchiseptica
complex IV with B. pertussis. B. bronchiseptica complex IV
strains were found to be more closely related to B. pertussis
than to the complex I B. bronchiseptica strains. A tree based on
prn nucleotide sequences also suggested a closer relationship
of complex IV strains to B. pertussis than to complex I strains.
A number of other features of complex IV strains were
consistent with their close relationship with B. pertussis. Most
complex IV strains were isolated from humans (80%), while
the majority of complex I strains were of animal origin (68%).
Almost all B. bronchiseptica complex IV strains were isolated
from patients with whooping cough symptoms. Further,
complex IV strains and B. pertussis shared an IS element,
Figure 3. Gene Content of the Differentially Hybridizing Virulence Loci between B. bronchiseptica Complex I and IV, as Determined by CGH
Each column represents one strain. Strain numbers and STs are indicated above the columns. Each row represents one ORF (in B. bronchiseptica RB50
gene order), ORF designations are shown to the right of the rows. In the case of tcfA and prn, the origins of the probes are indicated between
parentheses. The BP probe of tcfA was 100% similar to B. pertussis Tohama and 85.1% similar to B. bronchiseptica RB50. The BP prn probe was 100%
similar to B. pertussis Tohama and 86% similar to B. parapertussis 12822 and B. bronchiseptica RB50. The BB/BPP prn probes were both 100% similar to B.
parapertussis 12822 (BPP) and B. bronchiseptica RB50 (BB) and 86% similar to B. pertussis Tohama. The yellow-black-blue color scale indicates the
hybridization value relative to the reference; references are B. bronchiseptica RB50, B. parapertussis 12822, and B. pertussis Tohama. For B. bronchiseptica
RB50 and B. pertussis Tohama, the data in the figure are based on the genomic sequences. Yellow indicates decreased hybridization, black indicates
hybridization values comparative to the references, and blue indicates gene duplications. Intermediate values indicate partial deletions or sequence
divergence. Missing data are represented in gray.
DOI: 10.1371/journal.ppat.0010045.g003
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Evolution of Human-Associated Bordetella SpeciesFigure 4. Expression of LPS by B. bronchiseptica Complex I and Complex IV Strains and Gene Content Variation at the LPS Biosynthesis Locus
(A) Top: Electrophoretic LPS profiles obtained by tricine-SDS-PAGE and silver staining. Middle: Western blot of the same samples with mAb 36G3, which
detects band A. Bottom: Western blot of the same samples with mAb BL8, which detects band B.
(B) Gene content of the LPS biosynthesis locus as determined by CGH. See Figure 3 for details. For B. bronchiseptica RB50 and B. pertussis Tohama, the
data in the figure are based on the genomic sequences. The genes wbmPQRSTU represent an alternative LPS O-antigen biosynthesis sublocus that is
orthologous to the genes found in B. parapertussis 12822 [10] and B. bronchiseptica C7635E [26]. LPS genetic profiles as described in the text are
indicated at the top of the columns. Color scale as in Figure 3. Missing data are represented in gray.
DOI: 10.1371/journal.ppat.0010045.g004
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Evolution of Human-Associated Bordetella SpeciesIS1663, that was not found outside these two lineages. The
sharing of an IS element may be explained by either vertical
or horizontal transfer. The former suggests a common
ancestry, while the latter would point to niche sharing of B.
pertussis and B. bronchiseptica complex IV. It seems unlikely that
the association of complex IV strains with humans is due to a
sampling artifact, as the strains analyzed were from widely
separated geographic regions, including North America,
South America, and Europe. Thus, these strains were not
epidemiologically related.
Three STs (ST12, ST23, and ST27) found in complex I also
contained a high percentage of human strains (55%, 43%, and
77%, respectively). All other, nonhuman isolates of these STs
were collected from domesticated animals. Thus, both
complex I and IV contain B. bronchiseptica strains that are well
adapted to the human host. However, the particular relevance
of the human-associated lineage in complex IV appears to be
its evolutionary relationship with B. pertussis.T h eh i g h
frequency of human isolates observed in complex IV may be
due to the close interaction of humans with the animal hosts
in which these strains reside or to the fact that complex IV
strains are better adapted to a human environment than B.
bronchiseptica complex I strains. In either case, the B.
bronchiseptica complex IV infections of humans would be
zoonotic. Another intriguing possibility is that B. bronchiseptica
complex IV strains are to a large extent adapted to the human
host and primarily transmitted between humans.
Microarray-based CGH revealed 29 genes and IS1663 to be
more frequently present in, or more similar to, B. pertussis
orthologs in B. bronchiseptica complex IV than to complex I
strains. Of these genes, 16 were unique to B. pertussis and B.
bronchiseptica complex IV, suggesting they were acquired after
the common ancestor of complex IV and B. pertussis diverged
from complex I. With the exception of prn and tcfA, which
hybridized more strongly to the B. pertussis–derived probe, no
known virulence genes were identiﬁed among these 30 genes.
Conversely, 237 genes were absent or divergent in complex IV
compared to complex I strains, suggesting that the B.
bronchiseptica complex IV genome is decaying, as has been
assumed for B. pertussis and B. parapertussishu. Genome decay
has been associated with host restriction or niche change in a
number of pathogens such as Yersinia pestis [37,38] and
Burkholderia mallei [39] and has been suggested to be a driving
force of host restriction for B. pertussis and B. parapertussis as
well [10]. Likewise, the apparent preference of complex IV
strains for humans may also be associated with genome decay.
Because putative complex IV–speciﬁc sequences were not
represented on the microarray used here, we were unable to
address the possibility that complex IV strains have acquired,
through lateral transfer, genetic loci that may have promoted
host preference. However, gene acquisition appears to have
been a rare event in the evolution of B. pertussis and B.
parapertussis from B. bronchiseptica complex I [10].
Differences between complex IV strains and B. pertussis
were observed with respect to three major virulence factors,
Ptx, Dnt, and LPS. All B. bronchiseptica complex I strains
examined contained intact Ptx genes. Although conditions
under which the Ptx genes are expressed in B. bronchiseptica
have not been identiﬁed, their conservation suggests that they
may confer a selective advantage in the ecology of complex I
strains. In contrast to complex I strains, the genes encoding
Ptx and its secretion apparatus were deleted from most
complex IV strains (10 of 13). In the strains that did retain the
Ptx locus, no in vitro expression of Ptx was observed, even
though these strains were closely related to B. pertussis.
Another characteristic that sets complex IV strains apart
from all other mammalian bordetellae is that in eight of 13
strains, dnt was deleted. Dnt is an intracellular toxin that
activates the small GTPase Rho through deamidation or
polyamination [40]. It has been shown that Dnt is important
for turbinate atrophy and the colonization of the upper
respiratory tract by B. bronchiseptica in pigs [41].
Based on CGH, four LPS genetic proﬁles were distin-
guished. The LPS genetic locus was generally more poly-
morphic in complex IV strains than in complex I strains, and
deletions were observed in the O-antigen and trisaccharide
biosynthesis genes in some complex IV strains. In complex IV
strains with the LPS 4 proﬁle, the extent of deletion in the O-
antigen genes was very similar to that seen in B. pertussis
Tohama. B. pertussis does not produce repetitive O-antigen as
it lacks the wbm genes but makes a lipo-oligosaccharide that
consists of lipid A to which a single trisaccharide is attached
[26]. Like B. pertussis, four complex IV strains lacked the O-
antigen genes known to be present in the sequenced genomes
of B. bronchiseptica and B. parapertussishu. Despite the absence of
these genes, in at least one of these strains O-antigen was
detected by immunoblotting, suggesting that this strain
carries LPS genes distinct from those in RB50 or 12822.
The two LPS 4 strains, both isolated from humans, also lacked
the genes required for biosynthesis of the trisaccharide and
failed to produce trisaccharide detectable by immunoblot-
ting. The absence of the trisaccharide is intriguing in view of
the fact that it was found to be otherwise conserved in all
Bordetella strains analyzed.
It seems likely that in addition to gene loss and acquisition,
differences in gene regulation have signiﬁcantly contributed
to host adaptation [42]. The differences observed between
complex IV strains and B. pertussis, particularly with respect to
Ptx, Dnt, and LPS, may be due to differences in niches
occupied. Another possibility is that these differences have
arisen in response to immune competition between B.
bronchiseptica complex IV strains and B. pertussis. Gupta and
co-workers [43] provided evidence that immunodominant
surface antigens are organized into nonoverlapping combi-
nations as a result of selection by the host immune system.
This process could also have driven the inactivation and
conservation of virulence factors in mammalian bordetellae
infecting the same host. In a similar vein, Bjørnstad and
Harvill [44] hypothesized that, since B. pertussis and B.
parapertussishu both infect humans, they may have evolved to
evade cross-immunity by the other pathogen. The authors
propose that immune competition provides an explanation
for differences observed between B. pertussis and B. para-
pertussishu. For example, B. pertussis but not B. parapertussishu
expresses Ptx, although both contain the required genes.
Conversely, B. parapertussishu expresses O-antigen, while the
corresponding genes have been deleted from B. pertussis.
Similarly, the deletion of the genes for Ptx, Dnt, and genes
involved in trisaccharide syntheses by complex IV strains may
have been driven by immune competition with B. pertussis and
possibly also with B. parapertussishu.
The origin of the disease whooping cough is still a mystery.
Althoughthediseasehasverytypicalsymptomsinchildrenand
was one of the major causes of child mortality before the
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disease in Europe is found in 1540 [45]. The ﬁrst description of
an epidemic, which occurred in Paris, was given by Baillon in
1578[46].Particularlyinterestingaretheobservationsmadeby
Nils Rosen von Rosenstein in 1766, who wrote [47], ‘‘The
hooping cough never appeared in Europe originally, but was
transported thither from other parts of the world by means of
merchandise, seamen and animals. Its ﬁrst appearance in
Sweden cannot be determined with any certainty; but in
France it began in the year 1414.’’ In contrast, 16th- and 17th-
century descriptions of the disease and epidemics in Europe
are documented frequently in the literature [46]. The absence
of references to pertussis-like symptoms in the ancient
literature has been taken as evidence that the association of
B. pertussis with humans is of recent origin.
We propose that the association of B. pertussis with humans
is, in fact, ancient but that the introduction of B. pertussis into
Europe may be more recent. Complex IV strains showed a
degree of diversity that was comparable to complex I strains
(2.16 and 2.45, respectively), and thus, assuming that complex
IV strains are primarily adapted to the human host, this
association must be ancient. Parkhill et al. [10] previously
estimated the time to the LCA of a B. bronchiseptica complex I
strain (RB50) and B. pertussis to be 0.7 to 3.5 Mya, based on the
mean number of synonymous substitutions per synonymous
site of orthologous gene pairs. Our data indicate that current
B. pertussis strains expanded clonally from the B. pertussis–B.
bronchiseptica complex IV LCA 0.32 to 2.53 Mya, further
supporting an ancient association of B. pertussis with humans.
However, we cannot rule out the possibility that more recent
human-associated ancestors of B. pertussis are extinct or
undiscovered. Such recent ancestors would indicate a more
recent origin of B. pertussis.
Although it is tempting to speculate that the LCA of B.
pertussis and B. bronchiseptica complex IV was associated with
humans, the possibility remains that this association emerged
after the split with B. pertussis. A possible evolutionary
scenario (Figure 5) represents the adaptation of an ancestral
B. bronchiseptica complex I strain to humans or their hominid
ancestors. From this lineage, the LCA of B. bronchiseptica
complex IV and B. pertussis evolved, subsequently giving rise
to B. bronchiseptica complex IV and B. pertussis.
Recent emergence of a pathogenic clone from a more
ancient human-associated progenitor species has been
proposed as the mechanism for the origin of Mycobacterium
tuberculosis [48]. Although previous genetic analysis had
suggested that M. tuberculosis emerged as little as 20,000 years
ago, phylogenetic analysis of M. tuberculosis and a closely
related but more diverse group of smooth tubercle bacilli
indicated that this more broadly deﬁned species has been
associated with hominids for up to 3 million years.
Yersinia pestis, the causative agent of plague, is a clone that
evolved from Y. pseudotuberculosis 1,500 to 20,000 years ago,
shortly before the ﬁrst known pandemics of human plague,
and its recent origin is further suggested by the complete lack
of polymorphism in housekeeping genes [18]. Similarly, B.
pertussis also shows limited diversity. However, in contrast to Y.
pestis, which reveals absolutely no polymorphisms in house-
keeping genes, we observed three STs in B. pertussis. This may
suggest an older origin of B. pertussis compared to Y. pestis,
although other factors, such as population size and bottle-
necks, could also explain these differences. The most plausible
explanation from our data is that the association of B. pertussis
with humans originated in the LCA of B. pertussis and B.
bronchiseptica complex IV. Based on that assumption, the
apparent emergence of pertussis in Europe within the last 500
years may be attributable to import via travel or migration or
to the recent acquisition by B. pertussis of the ability to cause
more severe, whooping cough–like symptoms. Although most
of the B. bronchiseptica complex IV strains in our collection
were isolated from patients suspected to have pertussis, we
know little of the severity of the symptoms caused by these
strains. It is conceivable that B. bronchiseptica preceded B.
pertussis in Europe and that its disease was not documented
because of its relatively mild and nonspeciﬁc course.
The work presented here places the three sequenced
mammalian Bordetella strains within a phylogenetic context,
thereby facilitating rational selection of strains for further
genomic sequencing. In particular, sequencing of one or
more members of complex IV may shed more light on
processes involved in host adaptation and immune competi-
tion. Further, the identiﬁcation of a B. bronchiseptica lineage
which circulates in human populations may be important for
public health. In recent years, whole cell vaccines have been
replaced by acellular vaccines comprised of one to ﬁve
antigens derived from B. pertussis [49]. The acellular vaccines
induce a less cross-reactive immune response compared to
whole cell vaccines [50] and may therefore result in an
increase in B. parapertussis and B. bronchiseptica infections in
vaccinated human populations.
Figure 5. Model of the Evolution of the Mammalian Bordetellae
The bar on the left indicates increasing degrees of adaptation to the
human host. Arrows indicate descent; double arrows between com-
plexes indicate possible within-host immune competition. In boxes,
genetic events are shown that may have played a role in speciation and
niche adaptation. Numbers between parentheses refer to references. See
text for details.
DOI: 10.1371/journal.ppat.0010045.g005
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Bacterial strains. A total of 132 Bordetella isolates were used in this
study: 91 B. bronchiseptica, 9 B. parapertussishu, 3 B. parapertussisov, and 29
B. pertussis isolates (see Table S1). The three strains from which the
genome sequence has been determined, B. bronchiseptica RB50,B .
pertussis Tohama and B. parapertussis 12822 [10], were included. The
collection included clinical isolates from humans and a broad range
of animal species. Strains were grown on Bordet Gengou (BD,
Franklin Lakes, New Jersey, United States) agar supplemented with
15% sheep blood at 37 8C for 2 to 5 days. Chromosomal DNA was
isolated using the Wizard Genomic DNA Puriﬁcation Kit (Promega,
Madison, Wisconsin, United States), according to the manufacturers’
protocol for Gram-negative bacteria.
DNA sequencing. The nucleotide sequences were determined for
internal regions of seven housekeeping genes for all strains (http://
pubmlst.org/bordetella [51]). The nucleotide sequence of the prn
region encoding the extracellular domain of the surface-associated
autotransporter pertactin, P.69, was determined for 116 strains, with
the exclusion of the repeat regions 1 and 2 [35]. These regions are
comprised of amino acids repeats and are highly polymorphic due to
insertion or deletion of the repeat unit. Primer information is listed
in Table S3.
Detection of ISEs. The distribution of IS481, IS1001, IS1002, and
IS1663 was determined for all strains using PCR ampliﬁcation (see
Table S1). For PCR ampliﬁcation of IS481, IS1001, and IS1002,
primers were used that have been described previously [4,52]. Primer
characteristics are listed in Table S3.
LPS SDS-PAGE and Western blotting. BG-agar grownbacteria were
harvested, boiled in 13sample buffer (7.5% glycerol, 0.125 M Tris-HCl
[pH 6.8], 1.5% SDS), and treated with proteinase K [33]. Tricine-SDS-
PAGE was then performed in 4% stacking and 16% separating gels, as
previously described by Lesse et al. [53]. Silver staining was performed
as described by Tsai and Frasch [54]. LPS was transferred to PVDF
membranes (Amersham Biosciences, Buckinghamshire, United King-
dom) and blocked with 0.5% (w/v) Protifar nonfat dried milk, 0.5%
bovine serum albumin (w/v), and 0.1% Tween 20 in PBS. Immunoblot-
ting was performed with monoclonal antibodies 36G3 and BL-8,
directed against band A and band B LPS, respectively [31,32].
Sequence data analysis. Analysis of nucleotide sequence data was
performed using Bionumerics software package version 4.0 beta 4
(Applied Maths, Sint-Martens-Latem, Belgium). The Bordetella MLST
database can be accessed at http://pubmlst.org/bordetella [51].
For each locus in the MLST analysis, the allele sequences for all
strains were trimmed to a uniform length, and an allele number was
assigned to each unique allele sequence. The combination of the
allele numbers at the seven loci deﬁnes the ST or allelic proﬁle of
each strain. Construction of trees based on allelic proﬁles may not
accurately reﬂect the true genetic distance because both single and
multiple nucleotide polymorphisms are given equal weight. Con-
sequently, the degree of sequence difference between two alleles is
not quantitatively reﬂected in the MLST proﬁle. Conversely, tree
construction based on concatenated allele sequences does not take
into account the introduction of clustered multiple base substitutions
due to a single recombinational event. As a result, trees based on
MLST sequences often contain long branches, incorrectly suggesting
a large genetic distance. Therefore, we used a method designated as
split-MLST, in which each locus is split into a user-deﬁned number of
equally sized subloci (D. A. Diavatopoulos, P. Vauterin, L. Vauterin, F.
R. Mooi, and L. M. Schouls, unpublished data). Using this method, the
sensitivity of categorical clustering could be increased, without the
perturbing effect of recombination. The topology of the tree
appeared to vary if the number of subloci per MLST locus was lower
than ﬁve. However, above the value four, increasing the number of
subloci had no signiﬁcant effect on the topology of the tree, and we
therefore selected the lowest possible split value, ﬁve, resulting in a
total of 35 subloci.
The genetic diversity for each complex was calculated using the
Shannon-Weiner index of diversity (H) using the following formula:
H ¼ 
X
Pi   lnPi ð1Þ
where Pi is the frequency of the ith type [55].
For estimation of divergence times between complexes, we
calculated the pairwise mean distance (Ks) between alleles using






where Ks is the number of synonymous substitutions per synonymous
site and r is the molecular clock rate of Escherichia coli as determined by
Whittam [19] or by Guttman and Dykhuizen [20]. We used these two
ratesto calculate a range ofdivergencetimes.The divergence timewas
ﬁrst calculated for each combination of STs between complexes, and
from these the averaged age between complexes was calculated.
Comparative genomic hybridization. The preparation of PCR
product-based microarrays and the comparative genomic hybrid-
ization was performed essentially as described by Cummings et al.
(12). This study employed a new array design that contained all of the
probes from the ﬁrst array plus 1,417 additional probes that brought
the theoretical ORF coverage of these arrays up to 97.4% for B.
pertussis Tohama, 98.5% for B. bronchiseptica RB50, and 97.9% for B.
parapertussis 12822. Like the previously used array probes, these
additional probes were PCR products with a size of less than 300 base
pairs and ampliﬁed from the sequenced reference genomes with
ORF-speciﬁc oligonucleotides (Illumina, San Diego, California,
United States) designed with Microarray Architect (C. A. Cummings
and D. A. Relman, unpublished data).
A total of 26 complex I and 13 complex IV strains were hybridized
to the arrays. The genomic DNA of B. bronchiseptica was labeled with
Cy5 and hybridized to the array in conjunction with a Cy3-labeled
genomic DNA reference comprising the three sequenced mammalian
Bordetella genomes (B. pertussis Tohama, B. parapertussis 12822, and B.
bronchiseptica RB50). For the list of strains analyzed by CGH, see Table
S1. Labeled probes were puriﬁed using the Cyscribe GFX Puriﬁcation
Kit (Amersham Biosciences, Freiburg, Germany) following the
manufacturer’s protocol for probes produced by the CyScribe First-
Strand cDNA Labelling Kit. After puriﬁcation, the test and reference-
labeled DNA samples were concentrated to less than 8.5 ll using a
Savant SpeedVac SVC-100H. The test and reference samples were
combined and 150 lg of yeast tRNA (Invitrogen Life Technologies,
San Diego, California, United States) was added to block nonspeciﬁc
binding. The probe volume was adjusted to 24 ll with water and then
5.1 llo f2 0 3SSC (13SSC¼0.15 M NaCl plus 0.015 M sodium citrate)
and 0.9 ll of 10% sodium dodecyl sulfate (SDS) were added. Thirty
microliters of the probe was added to the array and covered with a 25
3 40 mm No. 1 glass coverslip. Hybridization was performed in
GeneMachines Hybchambers (Genomic Solutions, Ann Arbor, Mich-
igan, United States) with 2330 llo f3 3SSC to maintain humidity and
incubated at 65 8C overnight.
Arrayswerewashedin0.53SSC,0.03%SDSfor30s,0.13SSC,0.01%
SDS for 30 s, 0.053SSC, 0.005% SDS for 1 min, and 0.0253SSC for 1
min. The ﬁrst wash was performed at 65 8C, and the remaining washes
wereperformedatroomtemperature.SlidesweredriedusingaQuick-
DryFilteredAirGun(MatrixTechnologiesCorporation,Hudson,New
Hampshire, United States). Images were acquired on a PerkinElmer
ScanArray 4000XL scanner using Scanarray Express software (Perki-
nElmer Life and Analytical Sciences, Inc., Boston, Massachusetts,
UnitedStates).ImageswereanalyzedwithGenePixProsoftware(Axon
Instruments, Union City, California, United States).
Processed two-color array image data were submitted to an in-
house microarray database. Data were extracted using ﬁlters to
eliminate automatically and manually ﬂagged spots and spots with
very low background subtracted signal intensity (,150) in the
reference channel. B. bronchiseptica complex I and complex IV
enriched sequences were identiﬁed using the Signiﬁcance Analysis
for Microarrays software (SAM) [57]. The probes were analyzed using
26 complex I and 13 complex IV strains that were hybridized to the
arrays. SAM analysis was run using the two-class option with KNN
missing value imputation. In addition to a statistically signiﬁcant
difference, a 2-fold difference in mean signal intensity ratio for each
probe was also required.
Supporting Information
Dataset S1. CGH Data of the Mammalian Bordetellae
Found at DOI: 10.1371/journal.ppat.0010045.sd001 (5.0 MB XLS).
Dataset S2. CGH Data of the Differentially Hybridizing Probes
between Complexes I and IV as Identiﬁed by SAM
Found at DOI: 10.1371/journal.ppat.0010045.sd002 (207 KB XLS).
Table S1. Characteristics of the Strains Used in the MLST Analysis
Found at DOI: 10.1371/journal.ppat.0010045.st001 (16 KB PDF).
Table S2. Probes That Hybridized Differentially to B. bronchiseptica
Complex I and IV Genomes as Determined by SAM Analysis
Found at DOI: 10.1371/journal.ppat.0010045.st002 (19 KB PDF).
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Accession Numbers
The nucleotide sequences of pertactin have been deposited in
GenBank (http://www.ncbi.nlm.nih.gov/Genbank) under accession
numbers DQ141700 through DQ141711 and DQ141713 through
DQ141816.
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